Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
The Paris Brain Institute has acquired a new state-of-the-art multi-photon microscope thanks to the support of the Edmond J. Safra Foundation. This custom-built microscope will enable several teams at the Institute to carry out highly advanced...
Jaime de Juan-Sanz holds The Diane Barrière Chair « Molecular physiology of synaptic bioenergetics ». We met him in is new lab to talk about his background and research projects.
Julia Sliwa, a CNRS researcher at the CIM Brain Institute, received the Society for Neuroscience’s Peter and Patricia Gruber International Award for her research.
Stéphanie Baulac, head of the “Genetics and physiopathology of epilepsy” at Institut du Cerveau - ICM, receives the international “Michael Prize” award for her research in the field of epilepsy.
The 13th Annual Meeting of GEoPD (13-14 December 2018), is hosted by GEoPD French partners: Alexis Brice, Alexis Elbaz, Jean-Christophe Corvol, and Suzanne Lesage.
Violetta Zujovic, Olga Corti and Stéphane Hunot, researchers at Institut du Cerveau - ICM, obtained an important grant from the Sanofi Innovation Awards (iAwards) programme for their research.
Men and women face different chronic disease risks. Women, for example, are 1.5 times more likely to develop Alzheimer's disease. Although biological differences, cultural and social factors play a role, we do not fully understand the causes. Data...
Institut du Cerveau - ICM is seeking to recruit group leaders to reinforce its research in Neurophysiology, and welcomes applications for recruit highly talented individuals with the ambition to establish an internationally competitive research group...
NeoNeuro SAS and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group are pleased to announce that they have entered into a collaboration to validate the performance of the Aptamarker platform for Alzheimer's disease...
